Development of an itraconazole encapsulated polymeric nanoparticle platform for effective antifungal therapy

Xiang Ling; Zewei Huang; Jianzhao Wang; Jiarong Xie; Min Feng; Yang Chen; Farhana Abbas; Jiasheng Tu; Jun Wu; Chunmeng Sun

doi:10.1039/C5TB02453F

Development of an itraconazole encapsulated polymeric nanoparticle platform for effective antifungal therapy

Xiang Ling,^ab Zewei Huang,^c Jianzhao Wang,^a Jiarong Xie,^a Min Feng,^a Yang Chen,^d Farhana Abbas,^b Jiasheng Tu,*^a Jun Wu*^ef and Chunmeng Sun*^a

Author affiliations

* Corresponding authors

^a State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China
E-mail: suncm_cpu@hotmail.com

^b Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA

^c Sichuan Institute for Food and Drug Control, Chengdu 611731, China

^d Department of Key Laboratory of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China

^e Department of Biomedical Engineering, School of Engineering, Sun Yat-sen University, Guangzhou, China

^f Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instruments, Sun Yat-sen University, Guangzhou, Guangdong, China

Abstract

This study is to develop a novel itraconazole-loaded nanoparticle (ITZ-NP) platform for effective antifungal therapy. First, the monomethoxypoly(ethylene glycol)-b-poly(lactic acid) (mPEG-b-PLA) copolymer was prepared as a drug carrier material. Then the nanoparticles were formulated via a simple film hydration method. The copolymer and nanoparticles were characterized by standard methods, including ¹H NMR, ¹³C NMR, FT-NIR, DSC, XRPD, and particle size, zeta potential, morphology and physical examination. Furthermore, in vitro itraconazole release and antifungal activity were intensively evaluated. The results showed that the formed nanoparticles significantly enhanced sustained drug release and inhibited fungal infection. In addition, ITZ-NPs caused very mild hemolysis and slight venous irritation, indicating much better biocompatibility than marketed cyclodextrin formulations of ITZ. An Iin vivo biodistribution study via intravenous injection showed that ITZ-NPs could be effectively retained in blood circulation and selectively distributed in RES-rich organs compared with commercial cyclodextrin injection, with the verification of Re, Te, R_Te and Ce. In summary, the developed ITZ-NPs could reduce systemic toxicity, improve antifungal activity and act as a potential intravenous formulation of ITZ.

Journal of Materials Chemistry B

Development of an itraconazole encapsulated polymeric nanoparticle platform for effective antifungal therapy

Abstract

Article information

Download Citation

Author version available

Permissions

Development of an itraconazole encapsulated polymeric nanoparticle platform for effective antifungal therapy

Social activity

Search articles by author

Spotlight

Advertisements